In Vivo Delivery of RCAS Virus to Mice
Authors:
- 3 November 2014
- journal article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Protocols
- Vol. 2014 (11)
Abstract
Injection of RCAS viruses is highly customizable to the desired target tissue. RCAS viruses can be delivered into mice in vivo by injection of virus-producing cells or by injection of concentrated virus. When cells are injected, they persist for several days, continuously producing virus. Typically the decision of whether to inject virus-producing cells or concentrated virus is determined by the volume that can be reliably injected into a given tissue and the age of the animal when the virus delivery is performed. This general protocol describes the intraperitoneal injection of RCAS-expressing cells into mice and discusses the circumstances in which the injection of concentrated virus is preferred.Keywords
This publication has 5 references indexed in Scilit:
- Using the RCAS-TVA System to Model Human Cancer in MiceCold Spring Harbor Protocols, 2014
- Generation of High-Titer RCAS Virus from DF1 Chicken FibroblastsCold Spring Harbor Protocols, 2014
- A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectorsProceedings of the National Academy of Sciences, 2008
- The Absence of p53 Promotes Metastasis in a Novel Somatic Mouse Model for Hepatocellular CarcinomaMolecular and Cellular Biology, 2005
- Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in miceProceedings of the National Academy of Sciences, 1998